Status:
COMPLETED
Use of Platelet Rich Plasma in the Management of Acute Hamstring Muscle Strain Injury
Lead Sponsor:
Aspetar
Conditions:
Acute Hamstring Muscle Strain Injury
Eligibility:
MALE
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the therapeutic benefit of utilizing complex growth factor preparations (Platelet Rich Plasma (PRP) in the management of acute hamstring injuries. The hypothe...
Eligibility Criteria
Inclusion
- Acute onset posterior thigh pain
- MRI confirmed Grade I, II hamstring lesions
- \< 5 days from injury
- Able to perform Physiotherapy at ASPETAR (5 sessions/week)
- Available for follow-up
- Male
- Age \> 18 years
Exclusion
- Diabetes, immuno-compromised state
- Overlying skin infection
- Re-injury or Chronic ongoing hamstring injury
- Unwilling to comply with follow up
- Contraindication to MRI
- Needle Phobia
- Bleeding disorder or other medical contraindication to injection
- Medication increasing bleeding risk (e.g. Plavix)
- Concurrent other injury inhibiting rehabilitation
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01812564
Start Date
November 1 2009
End Date
October 1 2014
Last Update
January 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aspetar; Qatar Orthopaedic and Sports Medicine Hospital
Doha, Qatar, 29222